Last, we establish an animal model of GNAO1 encephalopathy and show that a dietary supplementation of Zn2+, the active component of the treatment, provides a significant rescue of the movement disorder and life-span shortening of the mutant animals. Here, GNAO1 is linked to Encephalopathy.